
No results matched your search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
AEZS | Toronto | CAD | Real-time | |
AEZS | NASDAQ | USD | Real-time | |
ET82 | Frankfurt | EUR | Delayed |
Aeterna Zentaris' (AEZS) underwriter has agreed to increase the size of the previous offering and purchase ~20.5M common shares at $1.45/share.Expected gross proceeds are ~$29.7M
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Sell | Neutral | Neutral |
Technical Indicators | BUY | Sell | Sell | Sell | BUY |
Summary | Buy | Neutral | Sell | Neutral | Neutral |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Deliberation Bearish | 5H | Current | |||
Completed Patterns | |||||
Bullish doji Star | 1D | 3 | Feb 23, 2021 | ||
Engulfing Bearish | 1W | 4 | Jan 24, 2021 | ||
Advance Block Bearish | 1W | 5 | Jan 17, 2021 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
Toronto | 1.500 | 1.490 | 1.500 | 397,820 | +5.63% | CAD | 26/02 | ||
NASDAQ | 1.170 | 1.160 | 1.180 | 9,082,381 | +4.46% | USD | 26/02 | ||
Frankfurt | 0.933 | 0.000 | 0.000 | 138,261 | -1.74% | EUR | 26/02 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
UBA | 8.15 | 8.35 | 8.00 | -0.05 | -0.61% | 16.09M | 26/02 | ||
Dangote Cement | 207.40 | 207.40 | 207.40 | -12.60 | -5.73% | 174.98K | 26/02 | ||
Zenith Bank | 25.45 | 25.90 | 25.30 | -0.40 | -1.55% | 26.61M | 26/02 | ||
Guaranty Trust Bank | 31.00 | 31.10 | 31.00 | -0.05 | -0.16% | 9.02M | 26/02 | ||
ETI | 5.20 | 5.25 | 5.10 | 0.00 | 0.00% | 2.56M | 26/02 | ||
Aiico | 1.15 | 1.15 | 1.15 | -0.05 | -4.17% | 619.30K | 26/02 | ||
Presco | 70.00 | 71.90 | 70.55 | +1.35 | +1.91% | 767.75K | 26/02 | ||
Champion Brew | 2.52 | 2.53 | 2.52 | -0.28 | -10.00% | 601.88K | 26/02 | ||
Mrs | 12.95 | 12.95 | 12.95 | -0.45 | -3.36% | 0.11K | 26/02 | ||
Cileasing | 5.60 | 5.20 | 5.20 | +0.07 | +1.36% | 1.91M | 26/02 |
Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review